InsiderTrades.com logo
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
From Colonial Metals   |   Ad
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
Get Your Free Gold Guide

MBX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $18,000,000.00
Insider Selling (Last 12 Months): $0.00

MBX Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at MBX Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MBX Biosciences Share Price & Price History

Current Price: $16.24
Price Change: ▲ Price Increase of +0.3 (1.88%)
As of 11/20/2024 01:00 AM ET

This chart shows the closing price history over time for MBX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
From Colonial Metals   |   Ad
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…
Claim your FREE 2024 Gold Guide

MBX Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/16/2024Edward T MathersDirectorBuy500,000$16.00$8,000,000.003,614,486View SEC Filing Icon  
9/16/2024Life Sciences X L.P. FrazierMajor ShareholderBuy625,000$16.00$10,000,000.004,552,774View SEC Filing Icon  
See Full Table
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
From Colonial Metals   |   Ad
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…
Claim your FREE 2024 Gold Guide

SEC Filings (Institutional Ownership Changes) for MBX Biosciences (NYSE:MBX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MBX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

MBX Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC16,400$0.43M0.0%N/A0.049%Search for SEC Filing on Google Icon
11/18/2024Teachers Retirement System of The State of Kentucky26,708$0.69M0.0%N/A0.080%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC22,269$0.58M0.0%N/A0.067%Search for SEC Filing on Google Icon
11/15/2024Frazier Life Sciences Management L.P.5,985,347$155.50M6.2%N/A17.909%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC16,400$0.43M0.0%N/A0.049%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC26,570$0.69M0.0%N/A0.080%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP2,937,853$74.26M0.0%N/A8.791%Search for SEC Filing on Google Icon
11/15/2024Soros Fund Management LLC30,000$0.78M0.0%N/A0.090%Search for SEC Filing on Google Icon
11/15/2024RA Capital Management L.P.1,511,334$39.26M0.5%N/A4.522%Search for SEC Filing on Google Icon
11/15/2024Point72 DIFC Ltd24,011$0.62M0.0%N/A0.072%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.15,600$0.41M0.0%N/A0.047%Search for SEC Filing on Google Icon
11/15/2024Maven Securities LTD50,000$1.30M0.0%N/A0.150%Search for SEC Filing on Google Icon
11/15/2024Point72 Asia Singapore Pte. Ltd.10,706$0.28M0.1%N/A0.032%Search for SEC Filing on Google Icon
11/14/2024NEA Management Company LLC3,614,486$93.90M5.1%N/A10.816%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 46,194$1.20M0.0%N/A0.138%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
MBX Biosciences logo
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.
Read More on MBX Biosciences

Today's Range

Now: $16.24
Low: $15.31
High: $16.75

50 Day Range

MA: $22.54
Low: $15.94
High: $25.98

52 Week Range

Now: $16.24
Low: $15.31
High: $27.50

Volume

166,656 shs

Average Volume

121,793 shs

Market Capitalization

$542.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of MBX Biosciences?

MBX Biosciences' top insider shareholders include:
  1. Life Sciences X LP Frazier (Major Shareholder)
  2. Edward T Mathers (Director)
Learn More about top insider investors at MBX Biosciences.

Who are the major institutional investors of MBX Biosciences?

MBX Biosciences' top institutional shareholders include:
  1. Frazier Life Sciences Management L.P. — 17.91%
  2. NEA Management Company LLC — 10.82%
  3. Wellington Management Group LLP — 8.79%
  4. RA Capital Management L.P. — 4.52%
  5. Maven Securities LTD — 0.15%
  6. The Manufacturers Life Insurance Company — 0.14%
Learn More about top institutional investors of MBX Biosciences stock.

Which institutional investors are buying MBX Biosciences stock?

In the previous quarter, MBX stock was purchased by institutional investors including:
  1. Frazier Life Sciences Management L.P.
  2. NEA Management Company LLC
  3. Wellington Management Group LLP
  4. RA Capital Management L.P.
  5. Maven Securities LTD
  6. The Manufacturers Life Insurance Company
  7. Soros Fund Management LLC
  8. Teachers Retirement System of The State of Kentucky
During the last year, these company insiders have bought MBX Biosciences stock:
  1. Life Sciences X LP Frazier (Major Shareholder)
  2. Edward T Mathers (Director)
Learn More investors buying MBX Biosciences stock.
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
From Colonial Metals   |   Ad
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
Get Your Free Gold Guide